ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,670.07
0.41%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. TG Therapeutics Inc (TGTX)

  7. TG Therapeutics Inc (TGTX) Noticias

TGTX TG Therapeutics Inc

13.57
-0.34 (-2.44%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
TG Therapeutics Inc TGTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.34 -2.44% 13.57 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
13.94 13.41 14.005 13.47 13.91
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202406:30GLOBETG Therapeutics Announces Additional Data Presentations for..
18/4/202406:00GLOBETG Therapeutics Awarded National Contract by the Department..
15/4/202406:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
08/3/202406:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
01/3/202406:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
29/2/202416:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202406:24EDGAR2Form 8-K - Current report
28/2/202406:00GLOBETG Therapeutics Provides Business Update and Reports Fourth..
27/2/202406:30GLOBETG Therapeutics Announces Issuance of Additional Patents for..
26/2/202406:00GLOBETG Therapeutics Announces European Launch of BRIUMVI®..
23/2/202406:30GLOBETG Therapeutics to Host Conference Call on Fourth Quarter..
20/2/202406:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
14/2/202420:53EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
14/2/202414:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/1/202406:37EDGAR2Form 8-K - Current report
10/1/202406:00GLOBETG Therapeutics Provides Preliminary Fourth Quarter and Full..
09/1/202408:20APSBiotech Massively Bid Up Before Opening Bell
09/1/202406:00GLOBETG Therapeutics Announces Global License Agreement with..
08/1/202417:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202410:02EDGAR2Form 144 - Report of proposed sale of securities
05/1/202406:30GLOBETG Therapeutics to Participate in the 42nd Annual J.P...
03/1/202415:46EDGAR2Form 144 - Report of proposed sale of securities
27/11/202306:30GLOBETG Therapeutics to Participate in the 6th Annual Evercore..
06/11/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202306:30GLOBETG Therapeutics to Participate in the 5th Annual Guggenheim..
01/11/202306:33EDGAR2Form 8-K - Current report
01/11/202306:30GLOBETG Therapeutics Provides Business Update and Reports Third..
30/10/202306:30GLOBETG Therapeutics to Host Conference Call on Third Quarter..
12/10/202310:00GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
11/10/202309:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
02/10/202306:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
29/9/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202306:30GLOBETG Therapeutics to Participate in the 2023 Cantor Global..
07/9/202306:30GLOBETG Therapeutics to Participate in the H.C. Wainwright 25th..
14/8/202308:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202306:29EDGAR2Form 8-K - Current report
01/8/202306:15GLOBETG Therapeutics Provides Business Update and Reports Second..
01/8/202306:00GLOBETG Therapeutics and Neuraxpharm Announce Ex-US..
31/7/202307:30GLOBETG Therapeutics to Host Conference Call on Second Quarter..
05/6/202306:30GLOBETG Therapeutics to Participate in the 2023 Jefferies..
02/6/202308:15GLOBETG Therapeutics Announces Presentation of Data from the..
01/6/202308:15GLOBETG Therapeutics Announces European Commission Approval for..
31/5/202306:30GLOBETG Therapeutics Announces Data from the ULTIMATE I & II..
04/5/202306:30GLOBETG Therapeutics to Participate in the Bank of America..
01/5/202306:30GLOBETG Therapeutics Provides Business Update and Reports First..

Su Consulta Reciente

NASDAQ
TGTX
TG Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados